Literature DB >> 24634781

PRELIMINARY BLOOD LIPID, LIPOPROTEIN AND GLUCOSE FINDINGS FROM THE GENOME-WIDE ASSOCIATION STUDY OF ADIPOSITY IN SAMOANS.

Nl Hawley, Hl Menard, G Agha, St McGarvey.   

Abstract

Samoans have been shown to exhibit alarmingly high rates of non-communicable disease such as obesity, diabetes and cardiovascular disease (CVD). A high NCD burden is usually characterized by high rates of biological risk factors within the population, such as elevated lipid, lipoprotein, and blood glucose levels. This report describes the prevalence of these biological risk factors in a population of 800 Samoan adults (39% male, n=312), aged 25-64 years. High levels of total cholesterol were found in 11.5% of men and 10.0% of women. Of the 800 individuals studied 617 (77.1%) had levels of LDL-cholesterol that were too high. A substantially greater proportion of women had levels of HDL-cholesterol, which is protective against CVD risk, that were too low (62.1% of women as compared to 27.9% of men). Men showed higher average levels of triglycerides, with more men than women being classified as having increased risk for CVD. High blood glucose was, conversely, more prevalent in women than men (12.5% of women, 7.7% of men). These biochemical findings support reports of a high NCD burden in Samoa. This disease burden has implications not only for the individual, but also the family and the national economy as the healthcare system is placed under increasing pressure. Primary prevention strategies for these diseases must be multifold, addressing the multiple determinants of NCDs.

Entities:  

Year:  2010        PMID: 24634781      PMCID: PMC3951835     

Source DB:  PubMed          Journal:  Samoa Med J        ISSN: 2076-7994


  18 in total

1.  Cardiovascular disease (CVD) risk factors in Samoa and American Samoa, 1990-95.

Authors:  S T McGarvey
Journal:  Pac Health Dialog       Date:  2001-03

2.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

3.  CHD and its risk factors in the People's Republic of China.

Authors:  S C Tao; Z D Huang; X G Wu; B F Zhou; Z K Xiao; J S Hao; Y H Li; R C Cen; X X Rao
Journal:  Int J Epidemiol       Date:  1989       Impact factor: 7.196

4.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

5.  Evaluation of the hexokinase-glucose-6-phosphate dehydrogenase method of determination of glucose in urine.

Authors:  J I Peterson; D S Young
Journal:  Anal Biochem       Date:  1968-05       Impact factor: 3.365

6.  Meta-analysis of coronary heart disease prevalence in India.

Authors:  R Gupta; V P Gupta
Journal:  Indian Heart J       Date:  1996 May-Jun

7.  Relations of body fat and fat distribution to the serum lipid, apolipoprotein and insulin concentrations of Samoan men and women.

Authors:  D J Galanis; S T McGarvey; J Sobal; L Bausserman; P D Levinson
Journal:  Int J Obes Relat Metab Disord       Date:  1995-10

8.  A genome-wide linkage scan identifies multiple chromosomal regions influencing serum lipid levels in the population on the Samoan islands.

Authors:  Karolina Aberg; Feng Dai; Guangyun Sun; Ember Keighley; Subba Rao Indugula; Linda Bausserman; Satupaitea Viali; John Tuitele; Ranjan Deka; Daniel E Weeks; Stephen T McGarvey
Journal:  J Lipid Res       Date:  2008-07-01       Impact factor: 5.922

9.  Adiponectin and type 2 diabetes in Samoan adults.

Authors:  Julia R Dibello; Ana Baylin; Satupaitea Viali; John Tuitele; Linda Bausserman; Stephen T McGarvey
Journal:  Am J Hum Biol       Date:  2009 May-Jun       Impact factor: 1.937

10.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Authors:  D J Gordon; J L Probstfield; R J Garrison; J D Neaton; W P Castelli; J D Knoke; D R Jacobs; S Bangdiwala; H A Tyroler
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.